Biotechnology
Companies applying molecular biology to develop therapeutics and diagnostics. High-risk/high-reward: valuations tie to clinical trial success, intellectual property and partnerships with big pharma.
| कंपनी | नवीनतम कीमत | कीमत में बदलाव | बाज़ार पूँजीकरण | ||
|---|---|---|---|---|---|
|
|
|
AbbVie Inc
ABBV
|
$284.95 |
+0.1%
|
$503.4 बिलियन |
|
|
|
Amgen Inc
AMGN
|
$449.745 |
+2.6%
|
$242.7 बिलियन |
|
|
|
Gilead Sciences, Inc
GILD
|
$156.86 |
+2.1%
|
$194.8 बिलियन |
|
|
|
Vertex Pharmaceuticals Inc
VRTX
|
$536.71 |
+2.3%
|
$136.2 बिलियन |
|
|
|
Regeneron Pharmaceuticals Inc
REGN
|
$820.57 |
+1.8%
|
$86 बिलियन |
|
|
|
Moderna Inc
MRNA
|
$199.76 |
-18.7%
|
$79.3 बिलियन |
|
|
|
CSL Ltd
CSL
|
AU$186.475 |
+1%
|
$62.8 बिलियन |
|
|
|
Natera Inc
NTRA
|
$398.95 |
-3.5%
|
$57.1 बिलियन |
|
|
|
argenx SE
ARGX
|
€783.4 |
-0.4%
|
$55 बिलियन |